rs199997425
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PP3_Strong
The NM_001605.3(AARS1):c.497T>G(p.Ile166Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000133 in 1,613,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001605.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 151962Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000175 AC: 44AN: 251142Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135774
GnomAD4 exome AF: 0.000136 AC: 199AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.000164 AC XY: 119AN XY: 727238
GnomAD4 genome AF: 0.0000987 AC: 15AN: 151962Hom.: 0 Cov.: 31 AF XY: 0.0000808 AC XY: 6AN XY: 74218
ClinVar
Submissions by phenotype
not provided Uncertain:4
Observed in multiple individuals referred for genetic testing at GeneDx and in published literature (Hoyer et al., 2014) who had a different genetic etiology for the phenotype; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 27535533, 25025039) -
The AARS c.497T>G; p.Ile166Ser variant (rs199997425) is reported in the literature in an individual affected with Charcot-Marie-Tooth disease type 1; however, this individual also carried a homozygous pathogenic variant in a different gene that likely explained their disease (Hoyer 2014). The p.Ile166Ser variant is found in the non-Finnish European population with an overall allele frequency of 0.03% (43/128858 alleles) in the Genome Aggregation Database. The isoleucine at codon 166 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, given the lack of clinical and functional data, the significance of the p.Ile166Ser variant is uncertain at this time. References: Hoyer H et al. Genetic diagnosis of Charcot-Marie-Tooth disease in a population by next-generation sequencing. Biomed Res Int. 2014;2014:210401. -
- -
PP3 -
Charcot-Marie-Tooth disease Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The p.I166S variant (also known as c.497T>G), located in coding exon 4 of the AARS gene, results from a T to G substitution at nucleotide position 497. The isoleucine at codon 166 is replaced by serine, an amino acid with dissimilar properties. This alteration was detected in an individual with Charcot-Marie-Tooth disease type 1, who also had a homozygous nonsense variant in SH3TC2 which was thought to be causative of disease (Høyer H et al. Biomed Res Int, 2014 Jul;2014:210401). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of Charcot-Marie-Tooth disease, axonal, type 2N (CMT2N); however, its contribution to the development of AARS-related early infantile epileptic encephalopathy (EIEE) is uncertain. -
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 166 of the AARS protein (p.Ile166Ser). This variant is present in population databases (rs199997425, gnomAD 0.03%). This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 25025039). ClinVar contains an entry for this variant (Variation ID: 157537). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AARS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at